SYS-CON MEDIA Authors: Maxime Charlès, RealWire News Distribution, Gilad Parann-Nissany, Kevin Benedict, Archie Hendryx

News Feed Item

Ivera Medical Announces Allowance of Key Patent by USPTO

SAN DIEGO, CA -- (Marketwired) -- 02/19/14 -- Ivera Medical, developer of the Curos Port Protector® disinfecting cap, announced the recent allowance by the United States Patent and Trademark Office of a significant patent regarding these products. Ivera Medical has the exclusive license for this patent, Publication number 2007/0112333. Additional information regarding the license agreement can be found in the Ivera press release dated August 28, 2008, "BD (Becton, Dickinson and Company) Licenses Intellectual Property to Ivera Medical Corporation."

"We believe this is a seminal patent for the disinfecting port protector space and we are thrilled to have the exclusive license for it," said Bob Rogers, CEO of Ivera Medical. "Upon issuance, this patent will serve as a cornerstone of our intellectual property portfolio, which already includes a strong suite of patents covering different aspects of this product family. We have invested great resources on our intellectual property and the allowance of this patent will further strengthen our position."

About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com

Contact:
Matt Heindel
Vice President, Business Development
Ivera Medical Corp.
858-752-9514

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.